MarketCap
Facebook
X
TelegramLand |
 Vereinigte Staaten |
IPO-Jahr |
2011 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
74.3 M |
Marktkapitalisierung |
$ 308 M |
EBITDA (LTM) |
$ -1.26 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 7.15 | -8.22 % | $ 28.5 M | Nasdaq Capital Market |  Israel |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Medpace Holdings
MEDP
|
$ 596.23 | -0.86 % | $ 17.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 83.04 | 0.51 % | $ 3.88 B | Nasdaq Global Select Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 330.45 | 0.25 % | $ 27.4 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 5.55 | -1.16 % | $ 514 M | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 13.28 | -4.39 % | $ 1.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.51 | 1.12 % | $ 2.06 B | Nasdaq Global Select Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Natera
NTRA
|
- | - | $ 35.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
OPKO Health
OPK
|
$ 1.22 | - | $ 847 M | Nasdaq Global Select Market | USA |
 |
Co-Diagnostics
CODX
|
$ 1.95 | -7.14 % | $ 2.59 M | Nasdaq Capital Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.36 | - | $ 408 M | Nasdaq Global Select Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Quidel Corporation
QDEL
|
- | - | $ 720 M | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Trinity Biotech plc
TRIB
|
$ 9.0 | 6.57 % | $ 3.23 B | Nasdaq Global Select Market |  Irlanda |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
- | - | $ 1.96 B | Nasdaq Global Market,SPB | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 85.73 | -5.03 % | $ 5.13 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 230.59 | 1.22 % | $ 25.6 B | NYSE,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Biomerica
BMRA
|
$ 1.65 | 4.1 % | $ 3.79 M | Nasdaq Capital Market | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.36 | -9.19 % | $ 109 K | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
DexCom
DXCM
|
$ 73.79 | 3.14 % | $ 28.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 169.31 | 2.14 % | $ 13.3 B | Nasdaq Global Select Market,SPB | Irlanda |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | Schweiz |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | Britain |
 |
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | USA |